This randomized , double-blind , placebo-controlled parallel-group study assessed the effects of sodium glucose cotransporter @ inhibition by dapagliflozin on insulin sensitivity and secretion in subjects with type @ diabetes mellitus ( T@DM ) , who had inadequate glycemic control with metformin ( with or without an insulin secretagogue ) .